HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enhanced distribution and anti-tumor activity of ergosta-4,6,8(14),22-tetraen-3-one by polyethylene glycol liposomalization.

Abstract
Ergosta-4,6,8(14),22-tetraen-3-one (ergone) was isolated from P. umbellatus, which has been demonstrated to possess a variety of pharmacological activities in vivo and in vitro. The purpose of this study was to evaluate the potent ergone formulations for cancer chemotherapy, the liposomal formulations were less toxic and provide longer systemic circulation time were selected as candidates of nanocarriers for ergone. The effect of modification polyethylene glycol (PEG) on the pharmacokinetics of liposome showed that the retaining time of ergone in blood circulation was prolonged by modified PEG. Moreover, the results of pharmacokinetic analysis showed that of PEG liposome was about 2.8 times higher than that of free PEG liposome after intravenous injection into normal rats due to the lower distribution into the reticuloendothelial system tissues. Since PEG liposome was able to stably encapsulate ergone in blood, area under plasma concentration-time curve of ergone was also extensively enhanced after intravenous dosing of ergone-PEG liposome into normal rats. In the in vivo studies utilizing solid tumor-bearing mice, it was confirmed that ergone-PEG liposome delivered remarkably larger amount of ergone to tumor tissue and provided more significant anti-tumor activity than free ergone. In conclusion, PEG liposome was an effective delivery formulation to achieve increased ergone release in tumor and therapeutic efficacy.
AuthorsYang Sun, Zhen Ji, Yingyong Zhao, Xuhua Liang, Xiaoyun Hu, Jun Fan
JournalJournal of nanoscience and nanotechnology (J Nanosci Nanotechnol) Vol. 13 Issue 2 Pg. 1435-9 (Feb 2013) ISSN: 1533-4880 [Print] United States
PMID23646655 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Cholestenones
  • Drug Carriers
  • Liposomes
  • Polyethylene Glycols
  • ergosta-4,6,8(14),22-tetraen-3-one
Topics
  • Animals
  • Antineoplastic Agents (administration & dosage, pharmacokinetics, pharmacology)
  • Cholestenones (administration & dosage, pharmacokinetics, pharmacology)
  • Drug Carriers
  • Female
  • Humans
  • Liposomes
  • Mice
  • Mice, Nude
  • Polyethylene Glycols (chemistry)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: